Elevance Health Rg
ELV
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
03/17/2025 - 21:15:00
Bid
03/17/2025 - 20:59:59
Bid
Volume
Ask
03/17/2025 - 20:59:59
Ask
Volume
430.59
+9.65 ( +2.29% )
430.57
6,100
430.87
1,500
More information
Analysis by TheScreener
14.03.2025
Evaluation Positive  
Interest Very strong  
Sensibility Low  
Analysis date: 14.03.2025
Global Evaluation
  Positive
The stock is classified in the positive zone since 25.02.2025.
Interest
  Very strong
Four stars since 14.03.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 14.03.2025 at a price of 420.94.
Evaluation
  Strongly undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
  Positive
 
The forty day technical trend is positive since 25.02.2025.
4wk Rel Perf
  16.31%
 
The four-week dividend-adjusted overperformance versus SP500 is 16.31%.
Sensibility
  Low
The stock has been on the low-sensitivity level since 11.02.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.94%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.29%.
Mkt Cap in $bn
  95.70
With a market capitalization >$8bn, ELEVANCE HEALTH is considered a large-cap stock.
G/PE Ratio
  1.27
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of .
LT P/E
  9.58
The estimated PE is for the year 2027.
LT Growth
  10.52%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  16
Over the last seven weeks, an average of 16 analysts provided earnings per share estimates.
Dividend Yield
  1.64%
The twelve month estimated dividend yield represents 15.72% of earnings forecasts.
Beta
  14
For 1% of index variation, the stock varies on average by 0.14%.
Correlation
  0.08
Stock movements are totally independent of index variations.
Value at Risk
  47.97
The value at risk is estimated at USD 47.97. The risk is therefore 11.39%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  31.03.2004